# Xttrium Laboratories, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/xttrium-laboratories-inc/30da7793-2a5c-4bf5-814c-05fc0921d353

> Inspection records and compliance data for Xttrium Laboratories, Inc. in Mount Prospect, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: Xttrium Laboratories, Inc.
- FEI Number: 3008436464
- City: Mount Prospect
- State: Illinois
- Country Name: United States
- Address Line 1: 1200 E Business Center Dr
- Zip Code: 60056
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - Xttrium Laboratories, Inc. - 2025-06-18](https://www.keypedia.com/records/483/xttrium-laboratories-inc/c29d29eb-46f3-4104-a21c-2f5a99530b5a) — source: FDA, date: June 18, 2025
- [FDA Inspection 1273417 - Xttrium Laboratories, Inc. - 2025-06-18](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/4ed04bd3-365c-4cff-8195-4116021f13be) — source: FDA, date: June 18, 2025
- [FDA Inspection 1273417 - Xttrium Laboratories, Inc. - 2025-06-18](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/ac02e451-de34-435b-bceb-4bf5ef75cc27) — classification: Official Action Indicated (OAI), source: FDA, date: June 18, 2025
- [483 - Xttrium Laboratories, Inc. - 2024-03-08](https://www.keypedia.com/records/483/xttrium-laboratories-inc/aef0adf8-fc5d-4131-883a-adf3dab56932) — source: FDA, date: March 8, 2024
- [FDA Inspection 1234354 - Xttrium Laboratories, Inc. - 2024-03-08](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/01777df6-bd08-47ed-9b42-5afa748c67ca) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2024
- [FDA Inspection 1230448 - Xttrium Laboratories, Inc. - 2024-02-06](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/b33bc865-f371-4b61-a458-934a851611c2) — classification: No Action Indicated (NAI), source: FDA, date: February 6, 2024
- [FDA Inspection 1046665 - Xttrium Laboratories, Inc. - 2018-03-15](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/e6a7f72a-a50d-407d-829f-53c9e35667d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2018
- [FDA Inspection 977965 - Xttrium Laboratories, Inc. - 2016-07-11](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/0672d8c2-af25-41a7-b2b9-ad1a49429db1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2016
- [FDA Inspection 985062 - Xttrium Laboratories, Inc. - 2016-05-25](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/5efb9150-ee25-4e3c-a224-e8f64be350ec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2016
- [FDA Inspection 857057 - Xttrium Laboratories, Inc. - 2013-12-05](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/297cb216-23c7-4351-834e-b76a910b39cc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2013
- [FDA Inspection 813925 - Xttrium Laboratories, Inc. - 2013-01-15](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/5d6aa9e9-b51a-4a7c-9672-79442cb7ce2a) — classification: No Action Indicated (NAI), source: FDA, date: January 15, 2013
- [FDA Inspection 809731 - Xttrium Laboratories, Inc. - 2012-12-11](https://www.keypedia.com/records/fda_inspections/xttrium-laboratories-inc/91e3706e-0d82-44cb-a007-4980a94ad602) — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2012

## Related Companies

- [Centaur Inc](https://www.keypedia.com/companies/centaur-inc/9106eaba-0e13-420b-a044-e6a6a9eb9459)
- [Grato Holdings, Inc.](https://www.keypedia.com/companies/grato-holdings-inc/c4d08434-07cf-4712-94fe-865ffad4ef6c)
- [DeVere Company, Inc.](https://www.keypedia.com/companies/devere-company-inc/13654ccb-6f8b-419e-9096-9f45ea3f9eae)
- [Gem State Partners Inc](https://www.keypedia.com/companies/gem-state-partners-inc/bef44f03-1e51-4a34-b810-46a54f422702)
- [Recipharm Uppsala AB](https://www.keypedia.com/companies/recipharm-uppsala-ab/2b5e3c54-3326-4cac-8628-6dc7236eb53f)
- [Apotheca Inc](https://www.keypedia.com/companies/apotheca-inc/2d1add93-4e54-42e4-8d66-6545c232e35c)
- [Hanseler AG](https://www.keypedia.com/companies/hanseler-ag/ccecca7c-671a-4232-adf8-2003f911ee83)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Bio-Technology General (Israel), Ltd.](https://www.keypedia.com/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8)

## Related Officers

- [Tyler M. Peterson](https://www.keypedia.com/people/tyler-m-peterson/207310ee-260c-4618-a515-9895a56e2ede)
- [investigator](https://www.keypedia.com/people/gabriel-bermudez-picart/3263ce6e-a27d-4d4b-953c-4477c17aa182)
- [Supreet K. Sran](https://www.keypedia.com/people/supreet-k-sran/1dab51f8-b483-4ccb-8b44-89fdc3b8100b)